Adco-Zetomax

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adco-Zetomax

Quick Facts

Property Description
Active Ingredient Lisinopril
Form Oral Tablet
Pharmacological Class Angiotensin-Converting Enzyme (ACE) Inhibitor
General Purpose Management of High Blood Pressure (Hypertension)
Origin Synthetic Dipeptide Derivative (Non-prodrug)

What Type of Medicine is Adco-Zetomax?

Adco-Zetomax is a prescription-only antihypertensive drug that belongs to the pharmacological class of Angiotensin-Converting Enzyme (ACE) inhibitors. The medicine's identity is defined by its sole active component, Lisinopril, which targets the body's primary systems for controlling vascular tension and fluid balance. Adco-Zetomax is a single-ingredient formulation (monotherapy), supplied in the form of an oral tablet. As an ACE inhibitor, it is recognized for its role in achieving sustained reductions in elevated blood pressure, contributing to long-term cardiovascular management.


The Composition of Adco-Zetomax: Lisinopril’s Unique Origin

The core component of the tablet is the active compound, Lisinopril, which is a synthetic dipeptide derivative typically supplied as the dihydrate salt. A key feature of Lisinopril is its classification as a non-prodrug; this means it is biologically active immediately upon ingestion and does not require initial metabolic conversion by the liver to exert its therapeutic effects. The compound’s structure is designed for direct action following oral administration.


What is the General Purpose of Adco-Zetomax?

The general purpose of Adco-Zetomax is to help manage and control chronic high blood pressure (hypertension) by reducing the pressure exerted on artery walls. It achieves this by acting on the Renin-Angiotensin-Aldosterone System (RAAS), where it competitively inhibits the Angiotensin-Converting Enzyme. This targeted action allows blood vessels to relax (vasodilation) and decreases the overall fluid volume. The net effect of this mechanism is a reduction of pressure against artery walls, easing the workload on the heart.

What side effects are possible with Adco-Zetomax?

Possible Side Effects and Safety Information

The safety profile for Adco-Zetomax (a combination medicine) is organized according to the frequency and type of documented adverse reactions, as established in regulatory texts.


Key Adverse Reactions and Frequency

Adverse reactions are classified by frequency, including Very Common (e.g., increased blood lipids), Common (e.g., headache, dizziness, fatigue, nausea), Uncommon (e.g., symptomatic low blood pressure), and Rare events (e.g., angioedema, decreased white blood cell count).

Reactions affect various body systems, including the Blood and Lymphatic system, Metabolism and nutrition, Nervous system, Vascular system, and Skin.

Frequency Examples of Adverse Reactions (System-Organ Classes)
Very Common Metabolism/Nutrition disorders (e.g., increased blood lipids)
Common Nervous system disorders (e.g., headache, dizziness, fatigue)
Uncommon Vascular disorders (e.g., low blood pressure, feeling faint)
Rare Serious hypersensitivity (e.g., Angioedema), Blood disorders

Serious Safety Information

Serious Adverse Reactions documented in official sources include Angioedema (severe swelling of the face, tongue, and throat, which may restrict breathing), Anaphylactic reactions, Renal dysfunction/failure, and Severe skin reactions (e.g., Stevens-Johnson syndrome, Toxic epidermal necrolysis).

Safety Restrictions and Limitations apply to certain groups and conditions:

  • Contraindicated in Pregnancy, especially during the second and third trimesters, due to risks to the fetus.
  • Contraindicated for patients who have previously experienced angioedema related to an ACE inhibitor or ARB medicine.
  • Not recommended for concomitant use with aliskiren in patients with diabetes or moderate to severe kidney impairment.

Dose- or Exposure-Related Risk: Long-term use and increased cumulative doses of the hydrochlorothiazide component are associated with an elevated risk of developing non-melanoma skin cancer (Basal Cell Carcinoma or Squamous Cell Carcinoma).

Overdose and Emergency Response

Overdose with Adco-Zetomax (Lisinopril) is characterized by an exaggerated effect of the medicine, with the primary documented clinical manifestation being profound hypotension, or an excessive fall in blood pressure. This effect may result in symptoms such as dizziness, lightheadedness, and sometimes stupor. Disturbances in heart rate, including both bradycardia (slowed heart rate) and tachycardia (rapid heart rate), are also documented overdose presentations.

An overdose may escalate to serious, life-threatening outcomes. Officially recognized severe consequences include the potential for circulatory shock, acute renal failure, and significant hyperkalemia (high potassium levels). Regulatory authorities mandate immediate medical attention must be sought without delay upon suspicion or confirmation of an overdose. The official guidance requires therapy to be immediately discontinued and the patient to be closely observed.

While no specific antidote is known for Lisinopril, treatment is symptomatic and supportive. Supportive measures described in official labeling include placing the patient in a supine position, administering intravenous infusion of normal saline to manage hypotension, and procedures such as gastric lavage if ingestion was recent. Hemodialysis is documented as a procedure that can remove Lisinopril from the body. Close monitoring of blood pressure, serum electrolytes, and renal function status is required during management. Patients with pre-existing compromised renal function are noted to have an increased risk of severe outcomes.

Therapeutic Uses of Adco-Zetomax

Quick Facts

  • Treatment Domain: Management of high blood pressure (Hypertension).
  • Potential Benefits: May help lower blood pressure and reduce the potential for serious cardiovascular events.

Adco-Zetomax is a prescription medication used to support the management of high blood pressure, also known as hypertension. It is typically prescribed to patients when treatment with the individual components is deemed appropriate by a healthcare provider.

The primary therapeutic goal of this medication is to help achieve and maintain healthy blood pressure levels. Lowering high blood pressure is intended to reduce the risk of developing serious long-term conditions. Consistent use of Adco-Zetomax, as directed, may contribute to the reduction of potential cardiovascular events such as stroke and heart attack, by decreasing the strain on the heart and arteries.

This medication is one available option in the comprehensive treatment plan for hypertension, which often includes lifestyle modifications. Further details regarding approved indications and the appropriate use of this combination product can be found in the prescribing information. Always consult a healthcare professional for personalized medical advice and to determine if this treatment option is suitable for your specific health needs.

Eligibility and Restrictions for Use

Who Can and Cannot Use Adco-Zetomax?

This section defines the populations eligible or restricted from using Adco-Zetomax (Lisinopril), based solely on official regulatory classifications.


Contraindicated Populations (Must Not Use)

Classification Population/Condition
Absolute Contraindication History of angioedema related to prior ACE inhibitor therapy.
Absolute Contraindication Hereditary or idiopathic angioedema.
Absolute Contraindication Pregnancy (during the second and third trimesters).
Absolute Contraindication Concomitant use with a Neprilysin Inhibitor (e.g., sacubitril/valsartan) or within 36 hours of discontinuing one.
Absolute Contraindication Hypersensitivity to Lisinopril or any other ACE inhibitor.

Restricted and Age-Specific Eligibility

Eligibility Status Restriction/Age Group
Allowed Adults (age 18 and older).
Allowed (Conditional) Pediatric patients aged 6 years and older with a GFR > 30 mL/min/1.73 m^2.
Not Recommended Children under 6 years of age (safety/effectiveness not established).
Conditional Use Patients with pre-existing renal impairment or volume depletion (requires caution).
Contraindicated Pregnancy (second and third trimesters) and Not Recommended during the first trimester and while breastfeeding.

Eligibility is primarily established for the adult population. Restrictions exist for younger patients and those with impaired organ function, necessitating specialized monitoring or dosage adjustment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation for Adco-Zetomax (Lisinopril) outlines specific constraints and interaction patterns, primarily categorized as pharmacokinetic and pharmacodynamic interactions.

Official Interaction Statements:

  • Contraindicated Combinations: Co-administration with Neprilysin Inhibitors (e.g., Sacubitril-containing products) is formally contraindicated due to the significantly increased risk of angioedema. A mandatory 36-hour separation period is required when transitioning between these medications.
  • Dual RAAS Blockade: Aliskiren is contraindicated for co-use specifically in patients with diabetes mellitus because of an elevated risk of severe adverse outcomes, including hyperkalemia and renal impairment.
  • Pharmacodynamic Effects: Co-use with Potassium-sparing Diuretics or Potassium Supplements may result in an additive effect, increasing the risk of hyperkalemia (elevated blood potassium levels).
  • Reduced Antihypertensive Effect: Co-administration of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may lessen the blood pressure-lowering effect of Lisinopril. This combination also carries an increased risk of renal function deterioration, particularly in elderly or volume-depleted patients.
  • Altered Exposure of Co-administered Drugs: Lisinopril reduces the renal clearance of Lithium, which can lead to increased serum lithium concentrations and potential toxicity.

Lisinopril is documented as being not metabolized by CYP450 enzymes, defining the lack of risk for CYP-mediated pharmacokinetic interactions. The absorption of Lisinopril is not clinically affected by food.

Mechanism of Action

Molecular Target and Binding

Adco-Zetomax functions as an inhibitor via a highly selective binding mechanism directed at the high-affinity site of the osteoclast's V-ATPase proton pump. The V-ATPase is essential for transporting hydrogen ions ( H^+) across the ruffled border membrane, which is the initial step in bone resorption. This precise molecular interaction defines the drug's primary role by interrupting the fundamental cellular machinery necessary for bone degradation.


Inhibition of the Resorption Process

This specific molecular binding blocks the essential translocation of protons from the osteoclast into the resorption lacuna, the microenvironment where bone matrix is broken down. The subsequent failure to properly acidify the lacuna prevents the optimal activity of acid proteases, such as cathepsin K. Consequently, Adco-Zetomax inhibits the local dissolution of the inorganic mineral matrix and the enzymatic degradation of collagen, the organic component of bone.


Physiological Marker Changes

The resulting cessation of osteoclast-mediated bone breakdown leads to a systemic decrease in the release of degradation products into the circulation. The measurable mechanistic consequence of this action is a reduction in circulating markers of bone resorption, including N-telopeptide (NTX) and C-telopeptide (CTX). This measured biochemical effect reflects the drug's activity strictly at the cellular and molecular levels.

Dosage and Administration Information

How to Use Adco-Zetomax

Adco-Zetomax, which contains the active ingredient Lisinopril, is a prescription medication administered via the oral route as a tablet or solution. It is characterized by a once-daily (qDay) dosing frequency, to maintain consistent systemic levels. Commonly, the medication is taken at approximately the same time each day, and intake is permissible with or without food.


Standard Dosage Regimens and Adjustments

Prescribing information details distinct starting doses and maintenance ranges based on the specific condition being managed:

  • Hypertension (Adults): The usual starting dose is 10 mg once daily, or 5 mg if a diuretic is already being used. The typical maintenance range is 20 mg to 40 mg once daily, with 80 mg as the maximum daily dose.
  • Heart Failure: Initial dosing is 5 mg once daily.

Dosage adjustments are generally made incrementally, based on clinical response, and are typically spaced at intervals of 1 to 2 weeks.


Population-Specific Use and Procedural Constraints

Specific dose modifications are defined for certain populations:

  • Renal Impairment: For patients with reduced kidney function (creatinine clearance CrCl 10-30 mL/min), the usual initial dose is halved, and starting doses are 2.5 mg for those on dialysis or with severe impairment.
  • Older Adults: A lower initial dose of 2.5 mg to 5 mg once daily is often considered to begin treatment.

Adco-Zetomax is typically used for long-term maintenance in chronic conditions, though a minimum treatment duration of 6 weeks is specified following an acute myocardial infarction.

Recent Clinical Evidence

Early Studies and Pharmacokinetics

Studies focused on the compound's interaction with specific receptors in the central nervous system. These early-stage studies were primarily conducted in vitro (in laboratory settings) and detailed the compound's potential effects on biochemical pathways.

Early research reported that the substance reached peak plasma concentration within 90 minutes. The compound is not metabolized and is primarily excreted unchanged by the kidneys. This suggests its effects are directly related to the parent drug.


Clinical Trials Summary

Type II Diabetes and Combination Group

Studies have evaluated the combination therapy in relation to long-term measures for patients with Type II Diabetes. A large, multicenter, randomized controlled trial (RCT) examined 500 participants over five years. The primary endpoint evaluated the incidence of cardiovascular events in the combination group compared to the control group receiving monotherapy.

Additionally, research examined changes in severe pain episodes during the first six months of treatment. Results were mixed, with a statistically significant difference observed only in the subgroup of patients over 65 years old.

Studies in Older Adult Populations

Studies involved people aged 70 and over with mild cognitive impairment. Research examined the protocol when the tablet was administered once daily. The 12-week study primarily evaluated the change in a specific measure of cognitive performance (MMSE score) and reported that no significant adverse events were observed during the study in this group.


Ongoing Research and Future Directions

An open-label trial investigated the onset of symptom resolution in patients receiving this treatment. This early study included a small cohort of 50 patients, and the findings are considered preliminary. Evidence remains limited, and interpretation should be approached with caution.

Further research is examining the use of the drug in specific pediatric populations, though no conclusive data is yet available. Consultation with a healthcare provider is necessary before making any treatment decisions.

Key Studies & References

  1. Medication Adherence and Glycemic Control in Older Adults with Type 2 Diabetes

Frequently Asked Questions (FAQ)

Common questions about Adco-Zetomax (FAQ)


Q: How quickly should I expect Adco-Zetomax to start working?

A: The active compound in Adco-Zetomax typically reaches its peak concentration in the blood within 90 minutes of being taken. The maximum blood pressure-lowering effect is typically achieved after four weeks of consistent use.

Q: Does taking Adco-Zetomax with food change how well it is absorbed?

A: According to official product information, the drug's absorption is not clinically affected by food. This means that Adco-Zetomax can be taken at any time, with or without a meal.

Q: Are there any known issues with Adco-Zetomax and kidney problems?

A: Yes, regulatory documents indicate that Adco-Zetomax is mainly eliminated from the body by the kidneys. It is associated with a risk of renal dysfunction, or kidney failure. For patients who already have impaired kidney function, dosage adjustments are specified.

Q: What is the maximum duration of treatment with Adco-Zetomax mentioned in official sources?

A: For chronic conditions like high blood pressure and heart failure, Adco-Zetomax is intended for long-term maintenance. While no specific maximum duration is stated, official documents specify a minimum treatment duration of six weeks following an acute heart attack.

Q: Does Adco-Zetomax interact with common pain relievers like paracetamol?

A: Official drug interaction databases generally indicate that no specific interaction has been found between Adco-Zetomax (Lisinopril) and paracetamol (acetaminophen).

Q: What does the research say about long-term use of Adco-Zetomax?

A: Adco-Zetomax is widely used as a long-term therapy for chronic conditions. Long-term use of one component often combined with lisinopril (hydrochlorothiazide) is associated with an elevated risk of non-melanoma skin cancer. The official safety profile guides long-term use.

Q: Can Adco-Zetomax cause tiredness or sleepiness?

A: Official safety documents list tiredness (fatigue) and dizziness as common side effects. Sleepiness (somnolence) is an effect that may occur due to the medicine's blood pressure-lowering action.

Q: Is it okay to drive while taking Adco-Zetomax?

A: Official label information indicates that because the medicine can cause side effects like dizziness, tiredness, or blurred vision, caution is necessary, and driving or operating machinery should be avoided if affected.

Q: Is there a possibility of becoming dependent on Adco-Zetomax?

A: Lisinopril, the active ingredient, is not classified as an addictive drug or a controlled substance by regulatory agencies. However, stopping the medicine abruptly can lead to rebound hypertension (a sudden increase in blood pressure).

Q: Are there any food or drinks that I should avoid when using Adco-Zetomax?

A: Due to the potential for the medicine to increase blood potassium levels (hyperkalemia), official sources advise caution regarding the intake of salt substitutes containing potassium, high potassium foods, and alcohol.

Q: What is the difference between Adco-Zetomax and [Similar Drug Name]?

A: Adco-Zetomax belongs to the ACE inhibitor class and works by blocking an enzyme. A similar drug from the ARB class (Angiotensin Receptor Blockers), such as Losartan, works instead by blocking the substance's effect on specific receptors. Both are used for blood pressure management but act slightly differently.

Q: Is Adco-Zetomax considered a high-risk medication?

A: Adco-Zetomax is a prescription-only antihypertensive drug that belongs to the ACE inhibitor class. It is associated with risks of serious adverse reactions such as angioedema and renal failure, which are documented in the official safety profile.

Q: Can Adco-Zetomax affect my ability to focus at work?

A: Common side effects of the medicine include dizziness and headache, which could indirectly impact concentration. Official documentation also reports that anxiety is sometimes reported as an adverse effect.

Q: How long does Adco-Zetomax typically stay in your system?

A: The time it takes for half of the drug to be eliminated from the body (the accumulation half-life) averages around 12.6 hours. The medicine is primarily cleared from the body through the kidneys.

Q: Does Adco-Zetomax contain lactose or gluten?

A: Official regulatory ingredient lists do not typically confirm the presence of lactose or gluten. Inactive ingredients can vary by manufacturer, so it is necessary to check the list on your specific package.

Q: If I feel better, is it okay to stop taking Adco-Zetomax early?

A: Regulatory guidance indicates that abruptly stopping the medicine is not advised, as this action carries the risk of a sudden and marked increase in blood pressure (rebound hypertension).

Q: How does Adco-Zetomax affect blood pressure?

A: Adco-Zetomax is an antihypertensive drug that acts by inhibiting the Angiotensin-Converting Enzyme (ACE). This action causes blood vessels to relax (vasodilation) and results in the lowering of elevated blood pressure.

Q: Are headaches a frequent side effect of Adco-Zetomax?

A: Yes, official safety documents categorize headache as a Common adverse reaction.

Q: Is Adco-Zetomax covered by most insurance plans?

A: As a widely-used generic prescription drug, lisinopril is generally covered by most major health insurance plans, including Medicare Part D and Medicaid. Coverage details and costs will depend on the individual's specific plan formulary.

Q: Has Adco-Zetomax been recalled for any reason?

A: Regulatory agencies occasionally issue recalls for certain batches or generic manufacturers of lisinopril due to manufacturing issues or quality concerns. Official recall information regarding specific batches or manufacturers is maintained by the FDA and other government health bodies.

Q: Are there any warnings about taking Adco-Zetomax with herbal products?

A: Research indicates that certain herbal products may interfere with the drug's effectiveness. Specifically, studies suggest that green tea may significantly decrease the amount of lisinopril absorbed into the bloodstream.

Q: What are the official guidelines for stopping Adco-Zetomax treatment?

A: Official guidance indicates that treatment discontinuation should be a planned process to prevent the risk of complications such as rebound high blood pressure.

Q: How is Adco-Zetomax typically packaged and sold?

A: Adco-Zetomax is supplied as oral tablets. It is generally packaged in prescription bottles or blister packs and must be kept in its original, tightly closed container.

Q: Does Adco-Zetomax have known effects on mood or anxiety?

A: While the side effect profile covers the nervous system, anxiety is sometimes reported as an adverse effect of the medicine.

Q: What happens if I take Adco-Zetomax too close to my bedtime?

A: Official instructions specify that the medicine should be taken at approximately the same time each day. Due to potential side effects like dizziness, taking it near bedtime may warrant caution, but no specific regulatory warning about night-time use is given.

Q: Is Adco-Zetomax used for chronic or short-term conditions?

A: Adco-Zetomax is used for long-term maintenance therapy in chronic conditions like heart failure and high blood pressure. It is also sometimes prescribed for a minimum duration of six weeks after an acute heart attack.

Q: How does Adco-Zetomax impact liver function?

A: Official safety data indicates a low rate of temporary elevations in liver enzymes, and rare cases of acute liver injury have been linked to the drug. These events are monitored and reported in official safety documents.

Q: Is it normal to feel a bit dizzy after starting Adco-Zetomax?

A: Yes, dizziness is classified as a Common side effect. It is an effect that is more likely to be experienced when a patient first starts taking the medicine or following an increase in dosage.

Q: Can I take Adco-Zetomax if I have high cholesterol?

A: High cholesterol itself is not listed as a contraindication for the medicine. However, the Very Common side effect of increased blood lipids documented in official sources may be a factor in the supervision of patients with pre-existing high cholesterol.

Q: What distinguishes Adco-Zetomax from over-the-counter medications for similar issues?

A: Adco-Zetomax (Lisinopril) is a prescription-only drug that is regulated by government agencies. This means it must be obtained through a prescription, which sets it apart from non-prescription, over-the-counter (OTC) medicines.

Q: Why is Adco-Zetomax sometimes prescribed for uses other than the main one listed?

A: Besides its main use for treating high blood pressure, Adco-Zetomax is officially approved for two other uses: reducing the signs and symptoms of systolic heart failure and reducing the death rate following an acute heart attack.

How should Adco-Zetomax be stored and disposed of?

How to Store and Dispose of Adco-Zetomax

Adco-Zetomax tablets require specific storage conditions to maintain their stability. The medicine must be stored at or below 25 °C and kept in a cool, dry place. Storage away from excess heat and moisture is required, and the tablets must not be frozen.


Packaging and Safety

Always store the medication in its original container and ensure the container is tightly closed. Do not use the medicine past the expiry date printed on the packaging. For safety, Adco-Zetomax must be stored out of the sight and reach of children.


Disposal Instructions

Unused or expired Adco-Zetomax should be disposed of in accordance with local legal requirements. To protect the environment, the medicine should not be discarded by flushing it down a toilet or pouring it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adco-Zetomax found in:

A-Z Index: